Thryv Therapeutics
Thryv Therapeutics
thryvtrx.com

Locations

Montreal, QC, Canada · Laval, QC, Canada · Montreal, QC, Canada · Montréal, QC, Canada

industry

Biotechnology · Biotechnology Research · Precision Medicine · Therapeutics

Size

11 - 50 employees

Stage

Other

founded in

2019

Thryv Therapeutics is a genetic disorder that causes a prolongation between the beginning of the QRS complex and the end of the T wave and T waves on the EKG, indicating a prolongation of ventricular repolarization and the action potential duration. The lengthening of this complex is associated with unexpected and life-threatening ventricular arrhythmias. Click below to learn more about our programs.

Something looks off?
Open jobs at Thryv Therapeutics

On-site & Remote